MUMBAI, India, Jan. 2 -- Intellectual Property India has published a patent application (202511102309 A) filed by Graphic Era, Dehradun, Uttarakhand, on Oct. 24, 2025, for 'a process for biomimetic nanoparticle synthesis for drug delivery.'
Inventor(s) include Yashaswi Singh.
The application for the patent was published on Dec. 12, under issue no. 50/2025.
According to the abstract released by the Intellectual Property India: "The invention relates to a biomimetic process for synthesizing nanoparticles (101-107) for drug delivery applications. The process employs a biological template (101) and a precursor solution (102) in a bio-inspired synthesis reactor (103), followed by stabilization (104), drug loading (105), purification (106), and formulation (107). The resultant nanoparticles mimic biological membranes, providing enhanced stability, controlled drug release, and site-specific targeting. This process ensures high biocompatibility, scalability, and efficiency for therapeutic applications."
Disclaimer: Curated by HT Syndication.
